A premature infant receiving care in a neonatal incubator

A BETTER
BEGINNING.

Developing Protego-PD to help prevent necrotizing enterocolitis in premature infants.

Discover Protego-PD
Regenerative biotherapeuticsWinston-Salem, North Carolina
One platform. Human possibility.

SCIENCE THAT STARTS
WITH LIFE.

A human placental extract platform, developed to address inflammation and support tissue development.

Our purpose

FROM LIFE’S FIRST MOMENTS.
FOR LIFE’S NEXT CHAPTERS.

Our mission is to help patients overcome inflammation-driven diseases, from infancy to old age, using regenerative biotherapeutics.

We begin with premature infants. Protego-PD is being developed to address NEC and the challenge of an immature digestive system.

Behind our science
A researcher pipetting samples into test tubes
The platform

NATURE’S COMPLEXITY.
A NEW POSSIBILITY.

Explore human placental extract
Find your path

A SHARED FUTURE.
YOUR PERSPECTIVE.

Build the next chapter together.

Explore our platform and development priorities, then connect with our team about potential collaboration.

Explore a partnership
News & research

THE SCIENCE MOVES ON.

All updates
Research

Peer-reviewed research on human placental extract

Read publication +
Company

NIH Phase IIB funding renewal

Read release +
A shared purpose

LET’S MOVE
SCIENCE FORWARD.

Start a conversation